ThursdayApr 29, 2021 12:04 pm

Ryah Group Inc. Uses Big Data, AI to Reshape Plant-Based Medicine 

RYAH recognizes the value data combined with analytics can bring to almost every industry. Company focused on becoming a technological leader in the plant-based treatment market. RYAH’s easy-to-operate line of products help foster a seamless dose-control experience that generates insightful data. A recent Forbes article called it the “oil” of the fourth industrial revolution (https://cnw.fm/VKdtU) while a Gartner article noted it was a core function for businesses focused on success in 2021 (https://cnw.fm/O3Zvf). Whatever it is called, data has become a hot commodity in today’s world, and the RYAH Group is dedicated to transforming patient care through big data and…

Continue Reading

WednesdayApr 28, 2021 11:53 am

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Retail Business to Bloom This Spring With Production of 50,000 Blister Packs

PULL starts production of roughly 50,000 blister pack gummies using Taste-T LLC’s successful proprietary manufacturing system Global CBD gummies market size estimated to grow at CAGR of 31.9% until 2025 PULL estimates $200,000 in revenue from initial batch, plans to produce three additional non-THC SKUs with varying levels of ultra-high potency CBD Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently announced it started production on roughly 50,000 Pure Chews edible gummy packs to be sold this Spring (https://cnw.fm/K57sl). The news came shortly…

Continue Reading

MondayApr 26, 2021 2:20 pm

Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Is ‘One to Watch’

Red White & Bloom considers itself a super state operator (not a multi-state operator), as it goes in with a sizable footprint and dominates the areas in which it operates before expanding The company currently operates, has cannabis assets in, or is in the process of closing cannabis assets in Michigan, Illinois, Florida, California, Oklahoma and Massachusetts Red White & Bloom is always looking to acquire new brands that will help to expand its brand awareness and advance its mission The company has established a major presence in Michigan through its investee, which has a total of 18 dispensaries and…

Continue Reading

WednesdayApr 21, 2021 10:58 am

Pac Roots Cannabis Corp. (CSE: PACR) (OTCQB: PACRF) (FSE: 4XM) Seeks to Step into Gap as Rivals Lose Market Share

Recent study delving into Canadian cannabis market revealed declining market shares for large Canadian cannabis companies Pac Roots and its peers have looked to increase their share of market, with Pac Roots recently increasing its total area under cultivation Key feature boosting Pac Roots’ prospects has been its focus on producing premium quality strains through meticulous cultivation process A recent study centered around the Canadian cannabis market and carried out by investment banking firm ATB Capital Markets in early April 2021 came up with a startling conclusion: Large Canadian cannabis cultivators had surprisingly seen their market shares decline between the…

Continue Reading

MondayApr 19, 2021 12:37 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Announces LOI Aimed at U.S. Expansion

Pure Extracts plans affiliate partnership to install cannabis and hemp extraction system in existing Michigan facility Company CEO notes excitement about launching into first US initiative with experienced and entrenched partners Agreement outlines planned renovation of existing 2,600-square-foot facility located in central Michigan Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp and functional mushrooms, has inked a letter of intent (“LOI”) to form a joint venture that paves the way for the company’s entrance into the United States. Based on the LOI, PULL will partner with the affiliate of a publicly traded multi-state…

Continue Reading

FridayApr 16, 2021 12:18 pm

Largely Untapped Market for Hallucinogenic Draws Attention of Researchers at XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT)

XPhyto Therapeutics Corp., a life sciences technology accelerator, is looking for ways to turn promising psychedelics into therapeutic pharmaceutical drugs, and recently added mescaline to its study profile Mescaline is illegal under U.S. federal law, but some state-centric efforts to legalize or decriminalize the hallucinogenic have launched in a manner similar to the populace effort that produced a wave of cannabis product legalization Mescaline has historically defied predictable outcomes by researchers, but advocates cite it as a means of successfully treating some mental health and substance abuse disorders A number of psychedelics production stocks saw huge gains during the past…

Continue Reading

MondayApr 12, 2021 2:21 pm

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) Signs Letter of Intent to Co-Develop Psychedelic Mushroom-Based Psilocybin Formulations

PULL signs Letter of Intent with Psyence Group to co-develop extraction techniques for production of psilocybin drug formulations Psyence is one of world’s first psychedelic mushroom companies operating a federally legal commercial cultivation and extraction facility PULL operates best-in-class processing infrastructure under Standard Processing License by Health Canada Near term milestones include Canada-based human clinical trials Pure Extracts Technologies (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, recently signed a Letter of Intent with the Psyence Group to develop premium extraction techniques for the production of…

Continue Reading

MondayApr 12, 2021 1:04 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Files First Order for Rapid COVID Test Kits Amid European Regulatory Approval

Bioscience technology accelerator XPhyto Therapeutics Corp. recently announced it had placed its first order for its Covid-ID Lab rapid, portable virus test from its German development partner XPhyto received approval for the test kit last month from European regulators with oversight of in vitro diagnostic device (CE-IVD) use certification and the internationally agreed-on ISO 13485 medical product quality standards The Covid-ID Lab is designed to help beleaguered industries and government regulators quickly screen for the COVID-19 virus at point-of-care sites, and the company expects to begin sales and distribution in April XPhyto has just completed a rebranding effort that includes…

Continue Reading

FridayApr 09, 2021 2:29 pm

RYAH Group Inc. Offers IoT Suite of Products Disrupting Future of Medicine

Every product features three parts: dosing device, formulation accessory and mobile app HIPPA-compliant cloud collects data along each step that is essential in tailoring personalized treatment plan RYAH offers multi-product ecosystem that provides remote-health solutions in patient treatment RYAH Group a digital health-care analytics and technology company, has developed an ecosystem of IoT products in its mission to advance the world's transition to remote-health solutions and data analytics in patient treatments (https://cnw.fm/EkHjl). Every product features three parts: the device, the formulation accessory (QR labeled product) and the mobile application. These parts work together to control the dosing while also capturing important…

Continue Reading

ThursdayApr 08, 2021 2:31 pm

XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT) Commercialization Team Set to Launch Rapid POC COVID Test Solution

Bioscience technology accelerator XPhyto Therapeutics Corp. is working with development partner 3a-diagnostics GmbH to roll out its pandemic-related virus diagnostic tool for the European market planned in April The test solution, dubbed “Covid-ID Lab,” received European regulatory approval last month XPhyto’s product is designed to be portable and rapid in its response time to help decrease testing operation costs and increase convenience of use News reports about the COVID-19 pandemic reflect a growing optimism that vaccine, mask and distancing protocols may be helping to drive down infection rates, although the reports note the virus continues to have a deadly effect…

Continue Reading

CanadianCannabisWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 905.674.5977